CASI PHARMACEUTICALS, INC. Retained Earnings
CASI PHARMACEUTICALS, INC. had Retained Earnings of -$637.16 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-04-26
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$637.16M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$624.86M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$620.57M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$613.63M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2022-12-31 | -$637.16M 20-F · filed 2023-04-26 | |
| 2022-09-30 | -$624.86M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$620.57M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$613.63M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$605.64M 20-F · filed 2023-04-26 | |
| 2021-09-30 | -$599.97M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$590.26M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$583.84M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$570.50M 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$556.81M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$540.36M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$532.03M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$523.91M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$512.07M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$502.43M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$487.11M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$478.94M 10-K · filed 2020-03-16 | -$478.94M 10-K · filed 2019-03-29 |
| 2018-09-30 | -$469.68M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$460.92M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$455.06M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$452.70M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$447.65M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$446.04M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$443.63M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$441.93M 10-K · filed 2018-03-29 | |
| 2016-09-30 | -$439.26M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$437.56M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$434.27M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$432.48M 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$430.78M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$429.17M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$427.08M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$425.27M 10-K · filed 2016-03-28 | |
| 2014-09-30 | -$423.68M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$402.14M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$400.52M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$399.07M 10-K · filed 2015-03-27 | |
| 2013-09-30 | -$397.76M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$396.32M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$394.47M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$393.33M 10-K · filed 2014-03-21 | |
| 2012-09-30 | -$392.97M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$391.78M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$381.32M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$378.79M 10-K · filed 2013-03-21 | |
| 2011-09-30 | -$379.79M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$378.48M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$374.23M 10-K · filed 2012-03-09 |